BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $355,360 | -28.5% | 9,416 | -13.7% | 0.01% | -25.0% |
| Q2 2023 | $497,105 | -11.8% | 10,911 | -21.4% | 0.01% | -14.3% |
| Q1 2023 | $563,378 | +76445.9% | 13,890 | -3.9% | 0.01% | -26.3% |
| Q4 2022 | $736 | -99.9% | 14,447 | +14.6% | 0.02% | -29.6% |
| Q3 2022 | $679,000 | -17.4% | 12,611 | -1.5% | 0.03% | -10.0% |
| Q2 2022 | $822,000 | -19.9% | 12,801 | -3.3% | 0.03% | -6.2% |
| Q1 2022 | $1,026,000 | -12.2% | 13,234 | -2.8% | 0.03% | -5.9% |
| Q4 2021 | $1,169,000 | -29.8% | 13,620 | -34.2% | 0.03% | -37.0% |
| Q3 2021 | $1,666,000 | -3.6% | 20,714 | -3.6% | 0.05% | -3.6% |
| Q2 2021 | $1,729,000 | -4.6% | 21,481 | -0.0% | 0.06% | -11.1% |
| Q1 2021 | $1,812,000 | -9.1% | 21,485 | -13.6% | 0.06% | +28.6% |
| Q4 2020 | $1,994,000 | -1.6% | 24,855 | -1.3% | 0.05% | -12.5% |
| Q3 2020 | $2,026,000 | +28.1% | 25,193 | +37.1% | 0.06% | +16.7% |
| Q2 2020 | $1,582,000 | +3.5% | 18,374 | -2.5% | 0.05% | -15.8% |
| Q1 2020 | $1,529,000 | -3.9% | 18,839 | -1.0% | 0.06% | +21.3% |
| Q4 2019 | $1,591,000 | -6.5% | 19,031 | -2.1% | 0.05% | -13.0% |
| Q3 2019 | $1,701,000 | +5.7% | 19,448 | -1.0% | 0.05% | +1.9% |
| Q2 2019 | $1,609,000 | +0.8% | 19,641 | 0.0% | 0.05% | -1.9% |
| Q1 2019 | $1,597,000 | +46.0% | 19,641 | +18.2% | 0.05% | +28.6% |
| Q4 2018 | $1,094,000 | -32.0% | 16,618 | -20.4% | 0.04% | -20.8% |
| Q3 2018 | $1,609,000 | +3.9% | 20,874 | -0.4% | 0.05% | -1.9% |
| Q2 2018 | $1,548,000 | +23.5% | 20,951 | +8.8% | 0.05% | +22.7% |
| Q1 2018 | $1,253,000 | +0.6% | 19,263 | 0.0% | 0.04% | +2.3% |
| Q4 2017 | $1,245,000 | -17.1% | 19,263 | -19.5% | 0.04% | -20.4% |
| Q3 2017 | $1,502,000 | -0.1% | 23,937 | -3.6% | 0.05% | -3.6% |
| Q2 2017 | $1,503,000 | +8.8% | 24,833 | -6.8% | 0.06% | +5.7% |
| Q1 2017 | $1,382,000 | +13.8% | 26,637 | -2.7% | 0.05% | +8.2% |
| Q4 2016 | $1,214,000 | -3.2% | 27,378 | +3.9% | 0.05% | -9.3% |
| Q3 2016 | $1,254,000 | +4.5% | 26,356 | -0.7% | 0.05% | +8.0% |
| Q2 2016 | $1,200,000 | +1.6% | 26,549 | -7.6% | 0.05% | 0.0% |
| Q1 2016 | $1,181,000 | +3.7% | 28,741 | -3.7% | 0.05% | +6.4% |
| Q4 2015 | $1,139,000 | +6.3% | 29,859 | -8.5% | 0.05% | -2.1% |
| Q3 2015 | $1,071,000 | -64.7% | 32,622 | -24.8% | 0.05% | -61.6% |
| Q2 2015 | $3,034,000 | -61.0% | 43,398 | -61.8% | 0.12% | -60.9% |
| Q1 2015 | $7,775,000 | -82.2% | 113,513 | -80.9% | 0.32% | -81.8% |
| Q4 2014 | $43,660,000 | +4.0% | 595,717 | +1.8% | 1.76% | -1.7% |
| Q3 2014 | $41,981,000 | +8.7% | 584,948 | +9.5% | 1.79% | +9.6% |
| Q2 2014 | $38,637,000 | -0.5% | 534,390 | +1.3% | 1.63% | -5.8% |
| Q1 2014 | $38,828,000 | +16.5% | 527,686 | +10.1% | 1.73% | +15.1% |
| Q4 2013 | $33,326,000 | +9.2% | 479,166 | +3.1% | 1.50% | -0.7% |
| Q3 2013 | $30,528,000 | +59.9% | 464,728 | +68.6% | 1.51% | +2.9% |
| Q2 2013 | $19,092,000 | – | 275,613 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |